top
Search terms
Results 1 - 2 of 2 - ordered by :
Escardio

Inclisiran—an investigational drug that “switches off” PCSK9 synthesis in the liver—lowers rates of low-density lipoprotein (LDL) cholesterol for up to one year in patients ...

Date : 29/08/2017
Escardio

Anacetrapib, an inhibitor of cholesteryl ester transfer protein (CETP) activity, lowers the risk of heart attack and related cardiovascular complications in patients receiving intensive statin ...

Date : 29/08/2017